Please ensure Javascript is enabled for purposes of website accessibility

Why Innovative Industrial Properties Is the Best REIT Pot Stock

By Sushree Mohanty – Updated Jun 24, 2020 at 4:18PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A favorite REIT/pot stock in 2019 is working wonders in 2020.

If you find it risky to invest directly in marijuana stocks, this real estate investment trust (REIT) might interest you. Innovative Industrial Properties (IIPR -2.26%) is an unconventional marijuana stock -- it's a REIT that provides real estate solutions to medical cannabis companies in the U.S.

Exceptional revenue growth through acquisitions

While most cannabis companies took a hard hit in 2019, Innovative Industrial Properties saw its stock rise by about 65% . The popularity of medical cannabis businesses in the U.S. is driving this revenue growth.

Medical cannabis bud in a prescription bottle

Image source: Getty Images.

Acquisitions were the main contributor to revenue growth. As of May 6, the company is the proud owner of 55 properties with about 4.1 million rentable square feet in various U.S. states. In 2020 alone, Innovative Industrial Properties has acquired nine properties that total about 1.1 million rentable square feet. The locations include Colorado, Florida, Illinois, Massachusetts, Michigan, Ohio, and Virginia. Innovative acquires these properties, then leases them out to mostly medical cannabis companies (which can have trouble getting funding to purchase them on their own), thereby earning a chunk of rental revenue.

Its recent fiscal 2020 first quarter showed a drastic 210% increase in revenue to $21.1 million from the year-ago quarter.

Added benefits: A dividend stock

Besides offering unconventional access to the marijuana sector, this company pays dividends -- an added benefit to investors. 

REIT stocks are well-known for being shareholder-friendly, paying 90% of their net profits as dividends. Innovative has an attractive forward dividend yield of 4.3%. That said, a high yield isn't everything -- consistency in dividend payments determines how stable the companies' financials are. Innovative has been consistently paying dividends since 2017 amid the market's ups and downs.

It hiked its quarterly dividend by 122% year-over-year in the first quarter, to $1 per share. Management noted the rise in rental revenue, net income, and adjusted funds from operations (AFFO) as the drivers behind the dividend increase.

Usually, with a REIT, we look at funds from operations (FFO) and AFFO, which paint a picture of its operating performance and give us an idea of how much cash is available to be paid out as dividends. Innovative saw a 236% increase in AFFO, to $17.8 million, and a 249% increase in net income to $11.5 million in the first quarter.

The company's commitment to providing value to shareholders is evident from its dividend hikes. In the second quarter, management raised the dividend by 6% from Q1, to $1.06 -- which is also an increase of 77% from the year-ago period. This marks the seventh increase since the company went public in December 2016. 

Medical cannabis has tremendous potential

What makes me support Innovative is its potential to grow through investments in the medical cannabis business. Compared with the recreational front, medical marijuana is a more stable and growing source of income. The medical segment held 71% of total worldwide legal cannabis revenue share in 2019 -- and if estimates by Grand View Research prove right, the global legal marijuana market could be worth $73.6 billion by 2027.

The market for medical cannabis is also vast in the U.S., where 33 states and the District of Columbia have legalized it -- whereas recreational cannabis is legal only in 11 states and D.C. Many more states are gearing up to make cannabis legal this year, opening doors of opportunity for this REIT. Innovative's shares are up 26% so far in 2020, while the SPDR S&P 500 ETF has lost 4.1%.

Innovative also ended the quarter with $108.3 million in cash and cash equivalents. Discussing the first-quarter results and COVID-19 crisis, management noted in a press release that "one of the pillars of our business strategy has consistently been a conservative, flexible balance sheet, and we believe we are exceptionally well-positioned to not only weather this unprecedented health crisis and economic disruption but to continue to make real estate investments on a long-term basis with best-in-class tenant operators."

It is a well-known fact that dividend payers can be the best stocks to own during an economic storm -- like the one we are facing right now because of the COVID-19 pandemic. This REIT/pot stock allows you to be a part of the evolving marijuana sector and also offers stability and potential for long-term growth. That said, if you are interested in waiting and enjoying the full potential of the evolving cannabis industry, then I believe Cronos Group (CRON 0.00%) and Aphria (APHA) are better positioned for 2020. They have strong balance sheets, innovative cannabis derivative products, and wise strategies for the future. 

Sushree Mohanty has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Innovative Industrial Properties. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Innovative Industrial Properties Stock Quote
Innovative Industrial Properties
$92.07 (-2.26%) $-2.13
Cronos Group Stock Quote
Cronos Group
$2.86 (0.00%) $0.00
Aphria Stock Quote

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/25/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.